DEUTSCHE BANK AG\ - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 95 filers reported holding AKERO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,594,098
-31.4%
110,599
-36.6%
0.00%0.0%
Q2 2023$8,149,739
-59.0%
174,550
-66.4%
0.00%
-63.6%
Q1 2023$19,878,940
-15.2%
519,575
+21.5%
0.01%
-15.4%
Q4 2022$23,437,028
+5312.7%
427,683
+3260.7%
0.01%
Q3 2022$433,000
+211.5%
12,726
-13.8%
0.00%
Q2 2022$139,000
-40.6%
14,763
-10.7%
0.00%
Q1 2022$234,000
-39.1%
16,531
-9.0%
0.00%
Q4 2021$384,000
-53.5%
18,171
-50.8%
0.00%
Q3 2021$826,000
-12.5%
36,967
-2.8%
0.00%
Q2 2021$944,000
+8.0%
38,045
+26.3%
0.00%
Q1 2021$874,000
-48.7%
30,129
-54.4%
0.00%
-100.0%
Q4 2020$1,704,000
-53.9%
66,055
-45.0%
0.00%
-66.7%
Q3 2020$3,695,000
+161.5%
119,991
+111.6%
0.00%
+200.0%
Q2 2020$1,413,000
+2378.9%
56,714
+1996.6%
0.00%
Q1 2020$57,000
+54.1%
2,705
+60.0%
0.00%
Q4 2019$37,000
+27.6%
1,691
+28.4%
0.00%
Q3 2019$29,0001,3170.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Skorpios Trust 3,271,829$125,180,17850.58%
COMMODORE CAPITAL LP 790,000$30,225,4004.60%
Redmile Group, LLC 2,044,389$78,218,3233.39%
SILVERARC CAPITAL MANAGEMENT, LLC 202,561$7,749,9843.20%
Ghost Tree Capital, LLC 275,000$10,522,0003.11%
Avidity Partners Management LP 2,447,000$93,622,2203.11%
Atlas Venture Life Science Advisors, LLC 594,251$22,736,0433.08%
Logos Global Management LP 400,000$15,304,0002.19%
Yiheng Capital Management, L.P. 1,125,791$43,072,7641.70%
Boxer Capital, LLC 831,495$31,8131.56%
View complete list of AKERO THERAPEUTICS INC shareholders